Researchers have identified an antioxidant in locally grown black tea leaves as a potential inhibitor of protease activity in SARS-CoV-2, the virus that causes COVID-19, Chiayi Chang Gung Memorial Hospital said on Wednesday.
A research team led by Wu Ching-yuan (吳清源), head of the hospital’s Department of Traditional Chinese Medicine, used a computer program to identify potential antiviral components in traditional plants, the hospital said in a statement.
Theaflavin, a polyphenolic compound, shows broad-spectrum antiviral activity against several viruses and could be used as a lead compound for the development of a SARS-CoV-2 inhibitor to target the DNA-directed ribonucleic acid (RNA) polymerase (RdRp) enzyme.
Photo copied by Lin I-chang, Taipei Times
In coronaviruses, RdRp catalyzes the replication of RNA from a template, making it an attractive candidate to help develop a treatment, Wu said.
RdRp in SARS-CoV-2 is also a primary target for the antiviral remdesivir, which the WHO has called the most promising drug available for the treatment of COVID-19, he said.
Remdesivir works by inhibiting RdRp, which many RNA viruses — including coronaviruses — use to replicate themselves.
The antiviral effects of theaflavin are similar to those of remdesivir, Wu said.
However, the exact in vivo effect is still unclear, and further research is needed to confirm the mechanism whereby theaflavin targets SARS-CoV-2, Wu said.
The findings were published by the American Society for Microbiology in the Journal of Medical Virology on March 13, the hospital said.
In other news, the Central Epidemic Command Center (CECC) on Thursday said that quinoline antimalarial drugs, which have been discussed as a possible treatment for COVID-19, are produced in Taiwan and could be made available if testing proves them to be effective against the novel coronavirus.
In a small French study, doctors used a drug in the quinoline family — hydroxychloroquine — to reduce the duration and severity of COVID-19 symptoms in people with mild cases, said Chang Shan-chwen (張上淳), convener of the center’s expert advisory panel.
If properly tested and approved, a process that normally takes 12 to 18 months, the drug could conceivably reduce the burden on medical resources such as quarantine facilities, Chang said.
Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the CECC, said that there is one manufacturer of quinoline drugs in Taiwan.
If the treatment were proved to be viable, the government’s first priority would be to guarantee domestic supply, Chen said.
The government could participate in the distribution of the drug on the precondition of not harming the manufacturer’s commercial interests, Chen said.
Internationally, drug distribution rights could be used diplomatically to build ties with international partners to address shortages amid the pandemic, he said.
Drugs that have been touted as potentially effective against COVID-19 have become the subject of heated competition in the past few weeks as governments scramble to combat the disease.
Remdesivir is being used on a trial basis in Taiwan and has reduced fevers in the three COVID-19 patients who have been treated with it, although its effect on overall recovery time is still being studied, Chang said.
Taiwanese scientists have engineered plants that can capture about 50 percent more carbon dioxide and produce more than twice as many seeds as unmodified plants, a breakthrough they hope could one day help mitigate global warming and grow more food staples such as rice. If applied to major food crops, the new system could cut carbon emissions and raise yields “without additional equipment or labor costs,” Academia Sinica researcher and lead author the study Lu Kuan-jen (呂冠箴) said. Academia Sinica president James Liao (廖俊智) said that as humans emit 9.6 billion tonnes of carbon dioxide compared with the 220 billion tonnes absorbed
The Taipei Mass Rapid Transit (MRT) Wanda-Zhonghe Line is 81.7 percent complete, with public opening targeted for the end of 2027, New Taipei City Mayor Hou You-yi (侯友宜) said today. Surrounding roads are to be open to the public by the end of next year, Hou said during an inspection of construction progress. The 9.5km line, featuring nine underground stations and one depot, is expected to connect Chiang Kai-shek Memorial Hall Station to Chukuang Station in New Taipei City’s Jhonghe District (中和). All 18 tunnels for the line are complete, while the main structures of the stations and depot are mostly finished, he
Taipei is to implement widespread road closures around Taipei 101 on Friday to make way for large crowds during the Double Ten National Day celebration, the Taipei Department of Transportation said. A four-minute fireworks display is to be launched from the skyscraper, along with a performance by 500 drones flying in formation above the nearby Nanshan A21 site, starting at 10pm. Vehicle restrictions would occur in phases, they said. From 5pm to 9pm, inner lanes of Songshou Road between Taipei City Hall and Taipei 101 are to be closed, with only the outer lanes remaining open. Between 9pm and 9:40pm, the section is
China’s plan to deploy a new hypersonic ballistic missile at a Chinese People’s Liberation Army Rocket Force (PLARF) base near Taiwan likely targets US airbases and ships in the western Pacific, but it would also present new threats to Taiwan, defense experts said. The New York Times — citing a US Department of Defense report from last year on China’s military power — on Monday reported in an article titled “The missiles threatening Taiwan” that China has stockpiled 3,500 missiles, 1.5 times more than four years earlier. Although it is unclear how many of those missiles were targeting Taiwan, the newspaper reported
RSS